{
  "generated_utc": "20251231_083052",
  "examples": [
    {
      "endpoint": "/api/tumor/quick_intake",
      "payload": {
        "cancer_type": "ovarian_hgs",
        "stage": "IIIC",
        "line": 2,
        "hrd_score": 35
      },
      "response": {
        "tumor_context": {
          "somatic_mutations": [],
          "copy_number_alterations": [],
          "fusions": [],
          "tmb": 5.2,
          "msi_status": null,
          "hrd_score": 35.0,
          "tmb_metrics": null,
          "msi_metrics": null,
          "hrd_metrics": null,
          "qc": null,
          "ihc": null,
          "signatures": null,
          "level": "L1",
          "priors_used": true,
          "completeness_score": 0.5,
          "tumor_context_source": "Quick Intake",
          "specimen_type": null,
          "report_date": null,
          "panel_name": null,
          "panel_version": null
        },
        "provenance": {
          "no_report_mode": true,
          "disease_priors_used": true,
          "disease_priors_version": "v1.0_bootstrap",
          "priors_refresh_date": "2025-12-31",
          "platinum_proxy_used": false,
          "confidence_version": "v1.0",
          "estimates": {
            "tmb": {
              "value": 5.2,
              "source": "disease_prior"
            },
            "msi_status": {
              "value": null,
              "source": "unknown"
            },
            "hrd_score": {
              "value": 35.0,
              "source": "manual"
            }
          }
        },
        "confidence_cap": 0.6,
        "recommendations": [
          "Level 1 analysis: Partial data provided. Full tumor NGS recommended for complete assessment.",
          "MSI status unknown. MSI testing (IHC/PCR or NGS) recommended for immunotherapy eligibility."
        ]
      }
    },
    {
      "endpoint": "/api/efficacy/predict",
      "payload": {
        "mutations": [
          {
            "gene": "TP53",
            "hgvs_p": "R248W"
          }
        ],
        "germline_status": "negative",
        "tumor_context": {
          "disease": "ovarian_hgs",
          "tmb": 5.0,
          "hrd_score": 30.0,
          "msi_status": "MSS",
          "completeness_score": 0.5
        },
        "disease": "ovarian",
        "options": {
          "include_all_drugs": true
        }
      },
      "response": {
        "drugs": [
          {
            "name": "adavosertib",
            "moa": "WEE1 inhibitor",
            "efficacy_score": 0.43,
            "confidence": 0.46,
            "evidence_tier": "consider",
            "badges": [
              "PathwayAligned"
            ],
            "evidence_strength": 0.0,
            "citations": [],
            "citations_count": 0,
            "clinvar": {
              "classification": null,
              "review_status": null,
              "prior": 0.0
            },
            "evidence_manifest": {
              "pubmed_query": null,
              "citations": [],
              "clinvar": {
                "classification": null,
                "review_status": null
              }
            },
            "insights": {
              "functionality": 0.0,
              "chromatin": 0.0,
              "essentiality": 0.0,
              "regulatory": 0.0
            },
            "rationale": [
              {
                "type": "sequence",
                "value": 0.1,
                "percentile": 0.1
              },
              {
                "type": "pathway",
                "percentile": 1.0,
                "breakdown": {
                  "ras_mapk": 0.0,
                  "tp53": 0.1
                }
              },
              {
                "type": "evidence",
                "strength": 0.0
              }
            ],
            "meets_evidence_gate": false,
            "insufficient_signal": false
          },
          {
            "name": "ceralasertib",
            "moa": "ATR inhibitor",
            "efficacy_score": 0.43,
            "confidence": 0.46,
            "evidence_tier": "consider",
            "badges": [
              "PathwayAligned"
            ],
            "evidence_strength": 0.0,
            "citations": [],
            "citations_count": 0,
            "clinvar": {
              "classification": null,
              "review_status": null,
              "prior": 0.0
            },
            "evidence_manifest": {
              "pubmed_query": null,
              "citations": [],
              "clinvar": {
                "classification": null,
                "review_status": null
              }
            },
            "insights": {
              "functionality": 0.0,
              "chromatin": 0.0,
              "essentiality": 0.0,
              "regulatory": 0.0
            },
            "rationale": [
              {
                "type": "sequence",
                "value": 0.1,
                "percentile": 0.1
              },
              {
                "type": "pathway",
                "percentile": 1.0,
                "breakdown": {
                  "ras_mapk": 0.0,
                  "tp53": 0.1
                }
              },
              {
                "type": "evidence",
                "strength": 0.0
              }
            ],
            "meets_evidence_gate": false,
            "insufficient_signal": false
          },
          {
            "name": "trametinib",
            "moa": "MEK inhibitor",
            "efficacy_score": 0.03,
            "confidence": 0.31,
            "evidence_tier": "consider",
            "badges": [],
            "evidence_strength": 0.0,
            "citations": [],
            "citations_count": 0,
            "clinvar": {
              "classification": null,
              "review_status": null,
              "prior": 0.0
            },
            "evidence_manifest": {
              "pubmed_query": null,
              "citations": [],
              "clinvar": {
                "classification": null,
                "review_status": null
              }
            },
            "insights": {
              "functionality": 0.0,
              "chromatin": 0.0,
              "essentiality": 0.0,
              "regulatory": 0.0
            },
            "rationale": [
              {
                "type": "sequence",
                "value": 0.1,
                "percentile": 0.1
              },
              {
                "type": "pathway",
                "percentile": 0.0,
                "breakdown": {
                  "ras_mapk": 0.0,
                  "tp53": 0.1
                }
              },
              {
                "type": "evidence",
                "strength": 0.0
              }
            ],
            "meets_evidence_gate": false,
            "insufficient_signal": false
          },
          {
            "name": "bevacizumab",
            "moa": "anti-VEGF",
            "efficacy_score": 0.03,
            "confidence": 0.31,
            "evidence_tier": "consider",
            "badges": [],
            "evidence_strength": 0.0,
            "citations": [],
            "citations_count": 0,
            "clinvar": {
              "classification": null,
              "review_status": null,
              "prior": 0.0
            },
            "evidence_manifest": {
              "pubmed_query": null,
              "citations": [],
              "clinvar": {
                "classification": null,
                "review_status": null
              }
            },
            "insights": {
              "functionality": 0.0,
              "chromatin": 0.0,
              "essentiality": 0.0,
              "regulatory": 0.0
            },
            "rationale": [
              {
                "type": "sequence",
                "value": 0.1,
                "percentile": 0.1
              },
              {
                "type": "pathway",
                "percentile": 0.0,
                "breakdown": {
                  "ras_mapk": 0.0,
                  "tp53": 0.1
                }
              },
              {
                "type": "evidence",
                "strength": 0.0
              }
            ],
            "meets_evidence_gate": false,
            "insufficient_signal": false
          },
          {
            "name": "pembrolizumab",
            "moa": "anti-PD-1",
            "efficacy_score": 0.03,
            "confidence": 0.31,
            "evidence_tier": "consider",
            "badges": [],
            "evidence_strength": 0.0,
            "citations": [],
            "citations_count": 0,
            "clinvar": {
              "classification": null,
              "review_status": null,
              "prior": 0.0
            },
            "evidence_manifest": {
              "pubmed_query": null,
              "citations": [],
              "clinvar": {
                "classification": null,
                "review_status": null
              }
            },
            "insights": {
              "functionality": 0.0,
              "chromatin": 0.0,
              "essentiality": 0.0,
              "regulatory": 0.0
            },
            "rationale": [
              {
                "type": "sequence",
                "value": 0.1,
                "percentile": 0.1
              },
              {
                "type": "pathway",
                "percentile": 0.0,
                "breakdown": {
                  "ras_mapk": 0.0,
                  "tp53": 0.1
                }
              },
              {
                "type": "evidence",
                "strength": 0.0
              }
            ],
            "meets_evidence_gate": false,
            "insufficient_signal": false
          },
          {
            "name": "olaparib",
            "moa": "PARP inhibitor",
            "efficacy_score": 0.018,
            "confidence": 0.21,
            "evidence_tier": "consider",
            "badges": [],
            "evidence_strength": 0.0,
            "citations": [],
            "citations_count": 0,
            "clinvar": {
              "classification": null,
              "review_status": null,
              "prior": 0.0
            },
            "evidence_manifest": {
              "pubmed_query": null,
              "citations": [],
              "clinvar": {
                "classification": null,
                "review_status": null
              }
            },
            "insights": {
              "functionality": 0.0,
              "chromatin": 0.0,
              "essentiality": 0.0,
              "regulatory": 0.0
            },
            "rationale": [
              {
                "type": "sequence",
                "value": 0.1,
                "percentile": 0.1
              },
              {
                "type": "pathway",
                "percentile": 0.0,
                "breakdown": {
                  "ras_mapk": 0.0,
                  "tp53": 0.1
                }
              },
              {
                "type": "evidence",
                "strength": 0.0
              }
            ],
            "meets_evidence_gate": false,
            "insufficient_signal": false,
            "sporadic_gates_provenance": {
              "germline_status": "negative",
              "level": "L1",
              "gates_applied": [
                "PARP_HRD_LOW",
                "SPORADIC_SUMMARY"
              ],
              "efficacy_delta": -0.012,
              "confidence_delta": 0.0,
              "rationale": [
                {
                  "gate": "PARP_HRD_LOW",
                  "verdict": "REDUCED",
                  "penalty": 0.6,
                  "hrd_score": 30.0,
                  "reason": "Germline negative, HRD<42 (score=30.0) \u2192 PARP reduced to 0.6x"
                },
                {
                  "gate": "SPORADIC_SUMMARY",
                  "germline_status": "negative",
                  "level": "L1",
                  "completeness": 0.5,
                  "original_efficacy": 0.03,
                  "final_efficacy": 0.018,
                  "efficacy_delta": -0.012,
                  "original_confidence": 0.21,
                  "final_confidence": 0.21,
                  "confidence_delta": 0.0,
                  "gates_applied": [
                    "PARP_HRD_LOW"
                  ]
                }
              ]
            }
          },
          {
            "name": "niraparib",
            "moa": "PARP inhibitor",
            "efficacy_score": 0.018,
            "confidence": 0.21,
            "evidence_tier": "consider",
            "badges": [],
            "evidence_strength": 0.0,
            "citations": [],
            "citations_count": 0,
            "clinvar": {
              "classification": null,
              "review_status": null,
              "prior": 0.0
            },
            "evidence_manifest": {
              "pubmed_query": null,
              "citations": [],
              "clinvar": {
                "classification": null,
                "review_status": null
              }
            },
            "insights": {
              "functionality": 0.0,
              "chromatin": 0.0,
              "essentiality": 0.0,
              "regulatory": 0.0
            },
            "rationale": [
              {
                "type": "sequence",
                "value": 0.1,
                "percentile": 0.1
              },
              {
                "type": "pathway",
                "percentile": 0.0,
                "breakdown": {
                  "ras_mapk": 0.0,
                  "tp53": 0.1
                }
              },
              {
                "type": "evidence",
                "strength": 0.0
              }
            ],
            "meets_evidence_gate": false,
            "insufficient_signal": false,
            "sporadic_gates_provenance": {
              "germline_status": "negative",
              "level": "L1",
              "gates_applied": [
                "PARP_HRD_LOW",
                "SPORADIC_SUMMARY"
              ],
              "efficacy_delta": -0.012,
              "confidence_delta": 0.0,
              "rationale": [
                {
                  "gate": "PARP_HRD_LOW",
                  "verdict": "REDUCED",
                  "penalty": 0.6,
                  "hrd_score": 30.0,
                  "reason": "Germline negative, HRD<42 (score=30.0) \u2192 PARP reduced to 0.6x"
                },
                {
                  "gate": "SPORADIC_SUMMARY",
                  "germline_status": "negative",
                  "level": "L1",
                  "completeness": 0.5,
                  "original_efficacy": 0.03,
                  "final_efficacy": 0.018,
                  "efficacy_delta": -0.012,
                  "original_confidence": 0.21,
                  "final_confidence": 0.21,
                  "confidence_delta": 0.0,
                  "gates_applied": [
                    "PARP_HRD_LOW"
                  ]
                }
              ]
            }
          },
          {
            "name": "rucaparib",
            "moa": "PARP inhibitor",
            "efficacy_score": 0.018,
            "confidence": 0.21,
            "evidence_tier": "consider",
            "badges": [],
            "evidence_strength": 0.0,
            "citations": [],
            "citations_count": 0,
            "clinvar": {
              "classification": null,
              "review_status": null,
              "prior": 0.0
            },
            "evidence_manifest": {
              "pubmed_query": null,
              "citations": [],
              "clinvar": {
                "classification": null,
                "review_status": null
              }
            },
            "insights": {
              "functionality": 0.0,
              "chromatin": 0.0,
              "essentiality": 0.0,
              "regulatory": 0.0
            },
            "rationale": [
              {
                "type": "sequence",
                "value": 0.1,
                "percentile": 0.1
              },
              {
                "type": "pathway",
                "percentile": 0.0,
                "breakdown": {
                  "ras_mapk": 0.0,
                  "tp53": 0.1
                }
              },
              {
                "type": "evidence",
                "strength": 0.0
              }
            ],
            "meets_evidence_gate": false,
            "insufficient_signal": false,
            "sporadic_gates_provenance": {
              "germline_status": "negative",
              "level": "L1",
              "gates_applied": [
                "PARP_HRD_LOW",
                "SPORADIC_SUMMARY"
              ],
              "efficacy_delta": -0.012,
              "confidence_delta": 0.0,
              "rationale": [
                {
                  "gate": "PARP_HRD_LOW",
                  "verdict": "REDUCED",
                  "penalty": 0.6,
                  "hrd_score": 30.0,
                  "reason": "Germline negative, HRD<42 (score=30.0) \u2192 PARP reduced to 0.6x"
                },
                {
                  "gate": "SPORADIC_SUMMARY",
                  "germline_status": "negative",
                  "level": "L1",
                  "completeness": 0.5,
                  "original_efficacy": 0.03,
                  "final_efficacy": 0.018,
                  "efficacy_delta": -0.012,
                  "original_confidence": 0.21,
                  "final_confidence": 0.21,
                  "confidence_delta": 0.0,
                  "gates_applied": [
                    "PARP_HRD_LOW"
                  ]
                }
              ]
            }
          },
          {
            "name": "carboplatin",
            "moa": "platinum alkylating agent",
            "efficacy_score": 0.03,
            "confidence": 0.21,
            "evidence_tier": "consider",
            "badges": [],
            "evidence_strength": 0.0,
            "citations": [],
            "citations_count": 0,
            "clinvar": {
              "classification": null,
              "review_status": null,
              "prior": 0.0
            },
            "evidence_manifest": {
              "pubmed_query": null,
              "citations": [],
              "clinvar": {
                "classification": null,
                "review_status": null
              }
            },
            "insights": {
              "functionality": 0.0,
              "chromatin": 0.0,
              "essentiality": 0.0,
              "regulatory": 0.0
            },
            "rationale": [
              {
                "type": "sequence",
                "value": 0.1,
                "percentile": 0.1
              },
              {
                "type": "pathway",
                "percentile": 0.0,
                "breakdown": {
                  "ras_mapk": 0.0,
                  "tp53": 0.1
                }
              },
              {
                "type": "evidence",
                "strength": 0.0
              }
            ],
            "meets_evidence_gate": false,
            "insufficient_signal": false
          }
        ],
        "run_signature": "184e4cc9-377e-4225-8b3b-2d7f440504c6",
        "scoring_strategy": {
          "approach": "curated_fallback_missing_alleles",
          "source": "unknown",
          "models_tested": [],
          "windows_tested": [],
          "ablation_mode": "SPE"
        },
        "evidence_tier": "consider",
        "provenance": {
          "run_id": "184e4cc9-377e-4225-8b3b-2d7f440504c6",
          "profile": "baseline",
          "cache": "miss",
          "flags": {
            "fusion_active": false,
            "evo_use_delta_only": true,
            "evidence_enabled": true,
            "confidence_v2": false
          },
          "sequence_scoring": {
            "mode": "curated_fallback_missing_alleles",
            "count": 1
          },
          "confidence_breakdown": {
            "top_drug": "adavosertib",
            "confidence": 0.46,
            "tier": "consider",
            "badges": [
              "PathwayAligned"
            ],
            "rationale": [
              {
                "type": "sequence",
                "value": 0.1,
                "percentile": 0.1
              },
              {
                "type": "pathway",
                "percentile": 1.0,
                "breakdown": {
                  "ras_mapk": 0.0,
                  "tp53": 0.1
                }
              },
              {
                "type": "evidence",
                "strength": 0.0
              }
            ],
            "S_contribution": 0.1,
            "P_contribution": 1.0,
            "E_contribution": 0.0,
            "pathway_disruption": {
              "tp53": 0.1
            }
          },
          "lifts": {
            "ablation_mode": "SPE"
          }
        }
      }
    },
    {
      "endpoint": "/api/efficacy/predict",
      "payload": {
        "mutations": [
          {
            "gene": "BRCA1",
            "hgvs_p": "E23V"
          }
        ],
        "germline_status": "negative",
        "tumor_context": {
          "disease": "ovarian_hgs",
          "tmb": 25.0,
          "hrd_score": 30.0,
          "msi_status": "MSS",
          "completeness_score": 0.9
        },
        "disease": "ovarian",
        "options": {
          "include_all_drugs": true
        }
      },
      "response": {
        "drugs": [
          {
            "name": "olaparib",
            "moa": "PARP inhibitor",
            "efficacy_score": 0.258,
            "confidence": 0.54,
            "evidence_tier": "consider",
            "badges": [
              "PathwayAligned"
            ],
            "evidence_strength": 0.0,
            "citations": [],
            "citations_count": 0,
            "clinvar": {
              "classification": null,
              "review_status": null,
              "prior": 0.0
            },
            "evidence_manifest": {
              "pubmed_query": null,
              "citations": [],
              "clinvar": {
                "classification": null,
                "review_status": null
              }
            },
            "insights": {
              "functionality": 0.0,
              "chromatin": 0.0,
              "essentiality": 0.0,
              "regulatory": 0.0
            },
            "rationale": [
              {
                "type": "sequence",
                "value": 0.1,
                "percentile": 0.1
              },
              {
                "type": "pathway",
                "percentile": 1.0,
                "breakdown": {
                  "ras_mapk": 0.0,
                  "tp53": 0.0
                }
              },
              {
                "type": "evidence",
                "strength": 0.0
              }
            ],
            "meets_evidence_gate": false,
            "insufficient_signal": false,
            "sporadic_gates_provenance": {
              "germline_status": "negative",
              "level": "L2",
              "gates_applied": [
                "PARP_HRD_LOW",
                "SPORADIC_SUMMARY"
              ],
              "efficacy_delta": -0.172,
              "confidence_delta": 0.0,
              "rationale": [
                {
                  "gate": "PARP_HRD_LOW",
                  "verdict": "REDUCED",
                  "penalty": 0.6,
                  "hrd_score": 30.0,
                  "reason": "Germline negative, HRD<42 (score=30.0) \u2192 PARP reduced to 0.6x"
                },
                {
                  "gate": "SPORADIC_SUMMARY",
                  "germline_status": "negative",
                  "level": "L2",
                  "completeness": 0.9,
                  "original_efficacy": 0.43,
                  "final_efficacy": 0.258,
                  "efficacy_delta": -0.172,
                  "original_confidence": 0.54,
                  "final_confidence": 0.54,
                  "confidence_delta": 0.0,
                  "gates_applied": [
                    "PARP_HRD_LOW"
                  ]
                }
              ]
            }
          },
          {
            "name": "niraparib",
            "moa": "PARP inhibitor",
            "efficacy_score": 0.258,
            "confidence": 0.54,
            "evidence_tier": "consider",
            "badges": [
              "PathwayAligned"
            ],
            "evidence_strength": 0.0,
            "citations": [],
            "citations_count": 0,
            "clinvar": {
              "classification": null,
              "review_status": null,
              "prior": 0.0
            },
            "evidence_manifest": {
              "pubmed_query": null,
              "citations": [],
              "clinvar": {
                "classification": null,
                "review_status": null
              }
            },
            "insights": {
              "functionality": 0.0,
              "chromatin": 0.0,
              "essentiality": 0.0,
              "regulatory": 0.0
            },
            "rationale": [
              {
                "type": "sequence",
                "value": 0.1,
                "percentile": 0.1
              },
              {
                "type": "pathway",
                "percentile": 1.0,
                "breakdown": {
                  "ras_mapk": 0.0,
                  "tp53": 0.0
                }
              },
              {
                "type": "evidence",
                "strength": 0.0
              }
            ],
            "meets_evidence_gate": false,
            "insufficient_signal": false,
            "sporadic_gates_provenance": {
              "germline_status": "negative",
              "level": "L2",
              "gates_applied": [
                "PARP_HRD_LOW",
                "SPORADIC_SUMMARY"
              ],
              "efficacy_delta": -0.172,
              "confidence_delta": 0.0,
              "rationale": [
                {
                  "gate": "PARP_HRD_LOW",
                  "verdict": "REDUCED",
                  "penalty": 0.6,
                  "hrd_score": 30.0,
                  "reason": "Germline negative, HRD<42 (score=30.0) \u2192 PARP reduced to 0.6x"
                },
                {
                  "gate": "SPORADIC_SUMMARY",
                  "germline_status": "negative",
                  "level": "L2",
                  "completeness": 0.9,
                  "original_efficacy": 0.43,
                  "final_efficacy": 0.258,
                  "efficacy_delta": -0.172,
                  "original_confidence": 0.54,
                  "final_confidence": 0.54,
                  "confidence_delta": 0.0,
                  "gates_applied": [
                    "PARP_HRD_LOW"
                  ]
                }
              ]
            }
          },
          {
            "name": "rucaparib",
            "moa": "PARP inhibitor",
            "efficacy_score": 0.258,
            "confidence": 0.54,
            "evidence_tier": "consider",
            "badges": [
              "PathwayAligned"
            ],
            "evidence_strength": 0.0,
            "citations": [],
            "citations_count": 0,
            "clinvar": {
              "classification": null,
              "review_status": null,
              "prior": 0.0
            },
            "evidence_manifest": {
              "pubmed_query": null,
              "citations": [],
              "clinvar": {
                "classification": null,
                "review_status": null
              }
            },
            "insights": {
              "functionality": 0.0,
              "chromatin": 0.0,
              "essentiality": 0.0,
              "regulatory": 0.0
            },
            "rationale": [
              {
                "type": "sequence",
                "value": 0.1,
                "percentile": 0.1
              },
              {
                "type": "pathway",
                "percentile": 1.0,
                "breakdown": {
                  "ras_mapk": 0.0,
                  "tp53": 0.0
                }
              },
              {
                "type": "evidence",
                "strength": 0.0
              }
            ],
            "meets_evidence_gate": false,
            "insufficient_signal": false,
            "sporadic_gates_provenance": {
              "germline_status": "negative",
              "level": "L2",
              "gates_applied": [
                "PARP_HRD_LOW",
                "SPORADIC_SUMMARY"
              ],
              "efficacy_delta": -0.172,
              "confidence_delta": 0.0,
              "rationale": [
                {
                  "gate": "PARP_HRD_LOW",
                  "verdict": "REDUCED",
                  "penalty": 0.6,
                  "hrd_score": 30.0,
                  "reason": "Germline negative, HRD<42 (score=30.0) \u2192 PARP reduced to 0.6x"
                },
                {
                  "gate": "SPORADIC_SUMMARY",
                  "germline_status": "negative",
                  "level": "L2",
                  "completeness": 0.9,
                  "original_efficacy": 0.43,
                  "final_efficacy": 0.258,
                  "efficacy_delta": -0.172,
                  "original_confidence": 0.54,
                  "final_confidence": 0.54,
                  "confidence_delta": 0.0,
                  "gates_applied": [
                    "PARP_HRD_LOW"
                  ]
                }
              ]
            }
          },
          {
            "name": "carboplatin",
            "moa": "platinum alkylating agent",
            "efficacy_score": 0.43,
            "confidence": 0.46,
            "evidence_tier": "consider",
            "badges": [
              "PathwayAligned"
            ],
            "evidence_strength": 0.0,
            "citations": [],
            "citations_count": 0,
            "clinvar": {
              "classification": null,
              "review_status": null,
              "prior": 0.0
            },
            "evidence_manifest": {
              "pubmed_query": null,
              "citations": [],
              "clinvar": {
                "classification": null,
                "review_status": null
              }
            },
            "insights": {
              "functionality": 0.0,
              "chromatin": 0.0,
              "essentiality": 0.0,
              "regulatory": 0.0
            },
            "rationale": [
              {
                "type": "sequence",
                "value": 0.1,
                "percentile": 0.1
              },
              {
                "type": "pathway",
                "percentile": 1.0,
                "breakdown": {
                  "ras_mapk": 0.0,
                  "tp53": 0.0
                }
              },
              {
                "type": "evidence",
                "strength": 0.0
              }
            ],
            "meets_evidence_gate": false,
            "insufficient_signal": false
          },
          {
            "name": "ceralasertib",
            "moa": "ATR inhibitor",
            "efficacy_score": 0.43,
            "confidence": 0.44,
            "evidence_tier": "consider",
            "badges": [
              "PathwayAligned"
            ],
            "evidence_strength": 0.0,
            "citations": [],
            "citations_count": 0,
            "clinvar": {
              "classification": null,
              "review_status": null,
              "prior": 0.0
            },
            "evidence_manifest": {
              "pubmed_query": null,
              "citations": [],
              "clinvar": {
                "classification": null,
                "review_status": null
              }
            },
            "insights": {
              "functionality": 0.0,
              "chromatin": 0.0,
              "essentiality": 0.0,
              "regulatory": 0.0
            },
            "rationale": [
              {
                "type": "sequence",
                "value": 0.1,
                "percentile": 0.1
              },
              {
                "type": "pathway",
                "percentile": 1.0,
                "breakdown": {
                  "ras_mapk": 0.0,
                  "tp53": 0.0
                }
              },
              {
                "type": "evidence",
                "strength": 0.0
              }
            ],
            "meets_evidence_gate": false,
            "insufficient_signal": false
          },
          {
            "name": "trametinib",
            "moa": "MEK inhibitor",
            "efficacy_score": 0.03,
            "confidence": 0.31,
            "evidence_tier": "consider",
            "badges": [],
            "evidence_strength": 0.0,
            "citations": [],
            "citations_count": 0,
            "clinvar": {
              "classification": null,
              "review_status": null,
              "prior": 0.0
            },
            "evidence_manifest": {
              "pubmed_query": null,
              "citations": [],
              "clinvar": {
                "classification": null,
                "review_status": null
              }
            },
            "insights": {
              "functionality": 0.0,
              "chromatin": 0.0,
              "essentiality": 0.0,
              "regulatory": 0.0
            },
            "rationale": [
              {
                "type": "sequence",
                "value": 0.1,
                "percentile": 0.1
              },
              {
                "type": "pathway",
                "percentile": 0.0,
                "breakdown": {
                  "ras_mapk": 0.0,
                  "tp53": 0.0
                }
              },
              {
                "type": "evidence",
                "strength": 0.0
              }
            ],
            "meets_evidence_gate": false,
            "insufficient_signal": false
          },
          {
            "name": "bevacizumab",
            "moa": "anti-VEGF",
            "efficacy_score": 0.03,
            "confidence": 0.31,
            "evidence_tier": "consider",
            "badges": [],
            "evidence_strength": 0.0,
            "citations": [],
            "citations_count": 0,
            "clinvar": {
              "classification": null,
              "review_status": null,
              "prior": 0.0
            },
            "evidence_manifest": {
              "pubmed_query": null,
              "citations": [],
              "clinvar": {
                "classification": null,
                "review_status": null
              }
            },
            "insights": {
              "functionality": 0.0,
              "chromatin": 0.0,
              "essentiality": 0.0,
              "regulatory": 0.0
            },
            "rationale": [
              {
                "type": "sequence",
                "value": 0.1,
                "percentile": 0.1
              },
              {
                "type": "pathway",
                "percentile": 0.0,
                "breakdown": {
                  "ras_mapk": 0.0,
                  "tp53": 0.0
                }
              },
              {
                "type": "evidence",
                "strength": 0.0
              }
            ],
            "meets_evidence_gate": false,
            "insufficient_signal": false
          },
          {
            "name": "pembrolizumab",
            "moa": "anti-PD-1",
            "efficacy_score": 0.0405,
            "confidence": 0.31,
            "evidence_tier": "consider",
            "badges": [],
            "evidence_strength": 0.0,
            "citations": [],
            "citations_count": 0,
            "clinvar": {
              "classification": null,
              "review_status": null,
              "prior": 0.0
            },
            "evidence_manifest": {
              "pubmed_query": null,
              "citations": [],
              "clinvar": {
                "classification": null,
                "review_status": null
              }
            },
            "insights": {
              "functionality": 0.0,
              "chromatin": 0.0,
              "essentiality": 0.0,
              "regulatory": 0.0
            },
            "rationale": [
              {
                "type": "sequence",
                "value": 0.1,
                "percentile": 0.1
              },
              {
                "type": "pathway",
                "percentile": 0.0,
                "breakdown": {
                  "ras_mapk": 0.0,
                  "tp53": 0.0
                }
              },
              {
                "type": "evidence",
                "strength": 0.0
              }
            ],
            "meets_evidence_gate": false,
            "insufficient_signal": false,
            "sporadic_gates_provenance": {
              "germline_status": "negative",
              "level": "L2",
              "gates_applied": [
                "IO_TMB_BOOST",
                "SPORADIC_SUMMARY"
              ],
              "efficacy_delta": 0.010500000000000002,
              "confidence_delta": 0.0,
              "rationale": [
                {
                  "gate": "IO_TMB_BOOST",
                  "verdict": "BOOSTED",
                  "boost": 1.35,
                  "tmb": 25.0,
                  "reason": "TMB-high (\u226520): 25.0 mut/Mb \u2192 Checkpoint inhibitor boost 1.35x"
                },
                {
                  "gate": "SPORADIC_SUMMARY",
                  "germline_status": "negative",
                  "level": "L2",
                  "completeness": 0.9,
                  "original_efficacy": 0.03,
                  "final_efficacy": 0.0405,
                  "efficacy_delta": 0.010500000000000002,
                  "original_confidence": 0.31,
                  "final_confidence": 0.31,
                  "confidence_delta": 0.0,
                  "gates_applied": [
                    "IO_TMB_BOOST"
                  ]
                }
              ]
            }
          },
          {
            "name": "adavosertib",
            "moa": "WEE1 inhibitor",
            "efficacy_score": 0.03,
            "confidence": 0.29,
            "evidence_tier": "consider",
            "badges": [],
            "evidence_strength": 0.0,
            "citations": [],
            "citations_count": 0,
            "clinvar": {
              "classification": null,
              "review_status": null,
              "prior": 0.0
            },
            "evidence_manifest": {
              "pubmed_query": null,
              "citations": [],
              "clinvar": {
                "classification": null,
                "review_status": null
              }
            },
            "insights": {
              "functionality": 0.0,
              "chromatin": 0.0,
              "essentiality": 0.0,
              "regulatory": 0.0
            },
            "rationale": [
              {
                "type": "sequence",
                "value": 0.1,
                "percentile": 0.1
              },
              {
                "type": "pathway",
                "percentile": 0.0,
                "breakdown": {
                  "ras_mapk": 0.0,
                  "tp53": 0.0
                }
              },
              {
                "type": "evidence",
                "strength": 0.0
              }
            ],
            "meets_evidence_gate": false,
            "insufficient_signal": false
          }
        ],
        "run_signature": "5f72101f-e95c-46b5-8dbc-fe86040a5c74",
        "scoring_strategy": {
          "approach": "curated_fallback_missing_alleles",
          "source": "unknown",
          "models_tested": [],
          "windows_tested": [],
          "ablation_mode": "SPE"
        },
        "evidence_tier": "consider",
        "provenance": {
          "run_id": "5f72101f-e95c-46b5-8dbc-fe86040a5c74",
          "profile": "baseline",
          "cache": "miss",
          "flags": {
            "fusion_active": false,
            "evo_use_delta_only": true,
            "evidence_enabled": true,
            "confidence_v2": false
          },
          "sequence_scoring": {
            "mode": "curated_fallback_missing_alleles",
            "count": 1
          },
          "confidence_breakdown": {
            "top_drug": "olaparib",
            "confidence": 0.54,
            "tier": "consider",
            "badges": [
              "PathwayAligned"
            ],
            "rationale": [
              {
                "type": "sequence",
                "value": 0.1,
                "percentile": 0.1
              },
              {
                "type": "pathway",
                "percentile": 1.0,
                "breakdown": {
                  "ras_mapk": 0.0,
                  "tp53": 0.0
                }
              },
              {
                "type": "evidence",
                "strength": 0.0
              }
            ],
            "S_contribution": 0.1,
            "P_contribution": 1.0,
            "E_contribution": 0.0,
            "pathway_disruption": {
              "ddr": 0.1
            }
          },
          "lifts": {
            "ablation_mode": "SPE"
          }
        }
      }
    }
  ]
}